We are live on ! Find out more
SR

Syntax Research Portfolio holdings

AUM $157M
1-Year Est. Return 16.51%
This Fund
S&P 500
This Quarter Est. Return
+7.32%
1 Year Est. Return
+16.51%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$141M
AUM Growth
-$4.04M
Cap. Flow
-$11.9M
Cap. Flow %
-8.48%
Top 10 Hldgs %
46.39%
Holding
182
New
7
Increased
31
Reduced
30
Closed
12

Top Sells

1
NTR icon
Nutrien
NTR
+$3.4M
2
AMT icon
American Tower
AMT
+$3.32M
3
NEM icon
Newmont
NEM
+$3.21M
4
COLD icon
Americold
COLD
+$2.6M
5
MRK icon
Merck
MRK
+$2.39M

Sector Composition

1 Technology 19.94%
2 Healthcare 5.03%
3 Industrials 4.92%
4 Financials 4.5%
5 Materials 4.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DLR icon
176
Digital Realty Trust
DLR
$64.3B
-15,000
Closed -$2.15M
FXI icon
177
iShares China Large-Cap ETF
FXI
$4.6B
-28,249
Closed -$1.01M
IEMG icon
178
iShares Core MSCI Emerging Markets ETF
IEMG
$149B
-20,095
Closed -$1.08M
LDOS icon
179
Leidos
LDOS
$13.4B
-15,000
Closed -$2.02M
WM icon
180
Waste Management
WM
$96.1B
-2,098
Closed -$486K
WY icon
181
Weyerhaeuser
WY
$17.7B
-40,000
Closed -$1.17M
XLRE icon
182
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.56B
-344
Closed -$14.4K

Similar funds

Syntax Research's Q2 2025 Portfolio in Review

As of Q2 2025, Syntax Research held 182 positions worth $141M, down 2.8% from $145M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Syntax Research withdrew a net $11.9M in Q2 2025, closing 12 positions and reducing 30 holdings. Its most notable exit was Americold, an estimated $2.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Syntax Research opened a new position in Zoetis worth $2.17M.

  • Syntax Research's largest Q2 2025 buy was Zoetis: 13,918 shares worth $2.17M.
  • Syntax Research added most to Thermo Fisher Scientific in Q2 2025, an estimated $2.35M increase.
  • Syntax Research's biggest Q2 2025 reduction was Nutrien, cutting an estimated $3.4M.
  • Syntax Research fully exited Americold in Q2 2025, selling an estimated $2.6M.
  • Syntax Research's ten largest holdings make up 46% of its $141M portfolio in Q2 2025.
  • Syntax Research opened 7 new positions and closed 12 in Q2 2025.
  • Syntax Research's portfolio value fell 2.8% quarter-over-quarter to $141M.

Based on Syntax Research's 13F filing for Q2 2025, filed 21 Jul 2025.